Moxifloxacin Hydrochloride Injection, Solution
Product Images NDC 67457-323

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride (NDC 67457-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of moxifloxacin hydrochloride, displaying its molecular framework with functional groups including a fluorinated aromatic ring, a cyclopropyl group, and ring systems characteristic of the quinolone class.*

FDA Label Image

Figure 1 (Image 02)

A line graph comparing plasma concentration levels (mcg/mL) of moxifloxacin hydrochloride over time (hours) for oral and intravenous (i.v.) doses. The graph shows concentration changes from 0 to 24 hours with oral dose represented by circles and i.v. dose by squares.*

FDA Label Image

Pouch Label (Image 03)

Label for Moxifloxacin Hydrochloride Injection, 400 mg/250 mL (1.6 mg/mL), in 0.8% Saline solution. The injection is a sterile, single-dose flexible plastic container for intravenous use. Manufactured by Mylan Institutional LLC. The label includes dosage instructions, storage conditions, and cautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.